Stockreport

Esperion Therapeutics: Biotech With Limited Upside, Hold [Seeking Alpha]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF ESPR faces pressure from emerging oral PCSK9i and CETP inhibitors, which offer superior LDL-c lowering and could erode market share. The company's capital structure i [Read more]